Mechanisms of disease: New mechanisms of antiarrhythmic actions

Nature Clinical Practice Cardiovascular Medicine

Volumn 1, Issue 1, 2004, Pages 37-41

  Gilmour Jr , Robert F ^a   Zipes, Douglas P ^b  

^a Department of Obstetrics Gynecology   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiarrhythmic drug; Connexin; Gene therapy; Ion channel; Restitution

Indexed keywords

4 [3 (4 BENZYL 1 PIPERIDINYL)PROPIONYL] 2,3,4,5 TETRAHYDRO 7 METHOXY 1,4 BENZOTHIAZEPINE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRETYLIUM; CALMODULIN; CONNEXIN 40; CONNEXIN 43; CONNEXIN 45; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FK 506 BINDING PROTEIN; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL HERG; RYANODINE RECEPTOR; SODIUM CHANNEL BLOCKING AGENT; VERAPAMIL; VIRUS VECTOR;

ADENOVIRUS; ANTIARRHYTHMIC ACTIVITY; CLINICAL STUDY; CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG TARGETING; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE FIBRILLATION; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CONNEXINS; GENE THERAPY; HUMANS; ION CHANNEL GATING; ION CHANNELS;

EID: 20444433923     PISSN: 17434297     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpcardio0024     Document Type: Review

References (50)

1. Zipes DP et al. (1998) Sudden cardiac death. Circulation 98: 2334-2351
2. Echt DS et al. (1991) Mortality and morbidity in patients receiving encainide, flecainide or placebo: the cardiac arrhythmia suppression trial. N Engl J Med 324: 781-788
3. Waldo AL et al.; SWORD Investigators (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 348: 7-12
4. Winfree AT (1998) Evolving perspectives during 12 years of electrical turbulence. Chaos 8: 1-20
5. Jais P et al. (1997) A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 95: 572-576
6. Antzelevitch C (2000) Electrical heterogeneity, cardiac arrhythmias, and the sodium channel. Circ Res 87: 964-965
7. Janse J and Wit AL (1989) Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 69: 1049-1169
8. Karma A (1994) Electrical alternans and spiral wave breakup in cardiac tissue. Chaos 4: 461-472
9. Fox JJ et al. (2002) Spatiotemporal transition to conduction block in canine ventricle. Circ Res 90: 289-296
10. Weiss JN et al. (2002) Electrical restitution and cardiac fibrillation. J Cardiovasc Electrophysiol 13: 292-295
11. Pastore JM et al. (1999) Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circ Res 99: 1385-1394
12. Riccio ML et al. (1999) Electrical restitution and spatiotemporal organization during ventricular fibrillation. Circ Res 84: 955-963
13. Garfinkel A et al. (2000) Preventing ventricular fibrillation by flattening cardiac restitution. Proc Natl Acad Sci USA 97: 6061-6066
14. Chen PS et al. (2003) A tale of two fibrillations. Circulation 108: 2298-2303
15. Fox JJ et al. (2002) Ionic mechanism of cardiac alternans. Am J Physiol Heart Circ Physiol 282: H516-H530
16. Salata JJ et al. (1998) A novel benzodiazepine that activates cardiac slow delayed rectifier K+ channels. Mol Pharmacol 53: 220-230
17. Kr through a reduction in C-type inactivation in guinea pig ventricular myocytes. J Physiol 522: 391-402
18. Marx SO et al. (2002) Requirement of a macromolecular signaling complex for β adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295: 496-499
19. Hua F et al. (2004) Suppression of electrical alternans by overexpression of HERG in canine ventricular myocytes. Am J Physiol Heart Circ Physiol 286: H2342-H2351
20. Miake J et al. (2002) Biological pacemaker created by gene transfer. Nature 419: 132-133
21. Ennis IL et al. (2002) Dual gene therapy with SERCA1 and Kir2.1 abbreviates excitation without suppressing contractility. J Clin Invest 109: 393-400
22. Samie FH et al. (2001) Rectification of the background potassium current: a determinant of rotor dynamics in ventricular fibrillation. Circ Res 89: 1216-1223
23. Nishikawa M and Huang L (2001) Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 12: 861-870
24. K,ACh gradients determine unequal left/right atrial frequencies and rotor dynamics. Cardiovasc Res 59: 863-873
25. Nattel S (2002) New ideas about atrial fibrillation 50 years on. Nature 415: 219-226
26. Goldhaber JI et al. (2002) Cellular basis of action potential duration alternans: role of the L-type calcium current and intracellular calcium cycling. Circulation 106: 228-228
27. Wehrens XHT et al. (2004) Protection from cardiac arrhythmias through ryanodine receptor-stabilizing protein calstabin2. Science 304: 292-296
28. Anderson ME (2004) Calmodulin kinase and L-type calcium channels: a recipe for arrhythmias? Trends Cardiovasc Med 14: 152-161
29. Satoh T and Zipes DP (1996) Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol 7: 833-842
30. Janse MJ et al. (2003) Mechanical effects on arrhythmogenesis: from pipette to patient. Prog Biophys Mol Biol 82: 187-195
31. Craelius W et al. (1988) Stretch activated ion channels in ventricular myocytes. Biosci Rep 8: 407-414
32. Clemo HF et al. (1999) Swelling-activated chloride current is persistently activated in ventricular myocytes from dogs with tachycardia-induced heart failure. Circ Res 84: 157-165
33. Niu W and Sachs F (2003) Dynamic properties of stretch-activated K+ channels in adult rat myocytes. Prog Biophys Mol Biol 82: 121-135
34. Isenberg G et al. (2003) Differential effects of stretch and compression on membrane currents and [Na+]c in ventricular myocytes. Prog Biophys Mol Biol 82: 43-56
35. Bode F et al. (2001) Tarantula peptide inhibits atrial fibrillation. Nature 409: 35-36
36. Chen RL et al. (2003) Stretch-induced regional mechanoelectric dispersion and arrhythmias in the right ventricle of anesthetized lambs. Am J Physiol Heart Circ Physiol 286: H1008-H1014
37. Komoro I and Yazaki Y (1993) Control of cardiac gene expression by mechanical stress. Ann Rev Physiol 55: 55-75
38. Allessie MA et al. (2002) Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54: 230-246
39. Li D et al. (2001) Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing induced congestive heart failure. Circulation 104: 2608-2614
40. Moreno AP (2004) Biophysical properties of homomeric and heteromultimeric channels formed by cardiac connexins. Cardiovasc Res 62: 276-286
41. Poelzing S et al. (2003) Heterogeneous connexin43 expression produces electrophysiological heterogeneities across the ventricular wall. Am J Physiol Heart Circ Physiol 286: H2001-H2009
42. Saffitz JE et al. (1999) Mechanisms of remodeling of gap junction distributions and the development of anatomic substrates of arrhythmias. Cardiovasc Res 42: 309-317
43. Kucera J et al. (2002) Localization of sodium channels in intercalated disks modulates cardiac conduction. Circ Res 91: 1176-1182
44. Poelzing S et al. (online 17 June 2004) Altered connexin43 expression produces arrhythmia substrate in heart failure [http://ajpheart.physiology.org/cgi/reprint/00346.2004v1] (accessed 15 September 2004)
45. Kostin S et al. (2004) Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis. Cardiovasc Res 62: 426-436
46. Yao J-A et al. (2003) Remodeling of gap junction channel function in epicardial border zone of healing canine infarcts. Circ Res 92: 437-443
47. Yamada KA et al. (2003) Up-regulation of connexin45 in heart failure. J Cardiovasc Electrophysiol 14: 1205-1212
48. Gaudesius G et al. (2003) Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ Res 93: 421-428
49. John SA et al. (1999) Connexin-43 hemichannels opened by metabolic inhibition. J Biol Chem 274: 236-240
50. Eloff BC et al. (2003) Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: evidence supporting a novel target for antiarrhythmic therapy. Circulation 108: 3157-3163